Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

80 results about "Enzyme structure" patented technology

Basic structure of enzyme. Enzymes are globular protein molecules that have three-dimensional shape with atleast one surface region having an area with a crevice or pocket. The crevice occupies only a small portion of the enzyme’s surface and is known as its active site.

Cas variants for gene editing

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. In some embodiments, fusion proteins of Cas9 and nucleic acid editing enzymes or enzyme domains, e.g., deaminase domains, are provided. In some embodiments, methods for targeted nucleic acid editing are provided. In some embodiments, reagents and kits for the generation of targeted nucleic acid editing proteins, e.g., fusion proteins of Cas9 and nucleic acid editing enzymes or domains, are provided.
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE

CAS variants for gene editing

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. In some embodiments, fusion proteins of Cas9 and nucleic acid editing enzymes or enzyme domains, e.g., deaminase domains, are provided. In some embodiments, methods for targeted nucleic acid editing are provided. In some embodiments, reagents and kits for the generation of targeted nucleic acid editing proteins, e.g., fusion proteins of Cas9 and nucleic acid editing enzymes or domains, are provided.
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE

Base editors and uses thereof

Some aspects of this disclosure provide strategies, systems, reagents, methods, and kits that are useful for the targeted editing of nucleic acids, including editing a single site within the genome of a cell or subject, e.g., within the human genome. The disclosure provides fusion proteins of nucleic acid programmable DNA binding proteins (napDNAbp), e.g., Cas9 or variants thereof, and nucleic acid editing proteins such as cytidine deaminase domains (e.g., novel cytidine deaminases generated by ancestral sequence reconstruction), and adenosine deaminases that deaminate adenine in DNA. Aspects of the disclosure relate to fusion proteins (e.g., base editors) that have improved expression and / or localize efficiently to the nucleus. In some embodiments, base editors are codon optimized for expression in mammalian cells. In some embodiments, base editors include multiple nuclear localization sequences (e.g., bipartite NLSs), e.g., at least two NLSs. In some embodiments, methods for targeted nucleic acid editing are provided.
Owner:THE BROAD INST INC

Multi-modal protein learning method and system

The invention discloses a multi-modal protein learning method, which comprises the following steps: extracting features in multi-modal biological data, the multi-modal biological data comprising a substrate, a product and an enzyme; performing mask processing on the features; and fusing the masked features to obtain a predicted value of the enzyme catalysis constant kcat. An auxiliary regularizer is introduced, and prediction of the enzyme catalysis constant is optimized. The SMILES expression of a substrate and a product is extracted based on a TRANSFORMER model, and an enzyme sequence is extracted based on ESM2. And extracting an enzyme structure chart by adopting a graph neural network GNN. Different features are masked or retained based on a non-uniform mechanism of pilot guidance to dynamically adjust retention or masking of the features. According to the method, the problem that the performance is poor when the value of the enzyme is predicted under the condition that modal data is missing in the existing method is solved, and the prediction accuracy and robustness are improved.
Owner:SHANGHAI TUSHEN BIOTECHNOLOGY CO LTD

Advanced treatment agent and treatment method for textile printing and dyeing wastewater

The invention discloses an advanced treatment agent for textile printing and dyeing wastewater and a treatment method. The advanced treatment agent comprises a component A and a component B, the component A comprises modified graphene oxide and an enzyme treatment agent; the component B comprises magnesium aluminum silicate, hydroxyapatite, hydroxypropyl methyl cellulose and chitosan, and the hydroxyapatite is coated with the magnesium aluminum silicate to form a core-shell structure. By adopting a modified graphene oxide immobilized enzyme structure, harmful components in water can be effectively adsorbed, so that the effect of greatly improving sewage purification is achieved, and meanwhile, the adsorption effect of the harmful components can be further improved by matching with aluminum-magnesium silicate coated hydroxyapatite, hydroxypropyl methyl cellulose and chitosan; meanwhile, bonding with the modified graphene oxide is beneficial to agglomeration and flocculation of substances, so that the flocculation capacity is improved, and floc separation is facilitated.
Owner:MIANYANG GANLION PRINTING & DYEING +1

Variants of thermostable DNA primases and uses thereof

The present invention relates to a functionally active mutated primase domain from an archaeal DNA primase belonging to the primase-polymerase family, comprising at least one amino acid substitution, wherein said mutated primase domain retains at least 50% of the template-independent terminal nucleotidyl transferase activity of the corresponding wild-type primase domain.
Owner:UNIVERCELLS FRANCE SAS

Systems and methods for sensing levadopa

PCT designated stage expiredWO2025117253A1Microbiological testing/measurementCatheterOxygenaseDihydroxyphenylalanine
A Levodopa-selective sensor is provided. A continuous levodopa monitor is also provided. The levodopa sensor includes a sensor area having a working electrode with a levodopa-selective chemistry configured for at least partial implantation in a host. The sensor also includes at least one membrane adjacent the levodopa-selective chemistry. The at least one membrane includes an enzyme domain that at least one enzyme selected from a tyrosinase; a mutated tyrosinase with specificity towards I-3,4-dihydroxyphenylalanine; a dihydroxyphenylalanine 4,5-dioxygenase; a mutated dihydroxyphenylalanine 4,5-dioxygenase with specificity towards I-3,4-dihydroxyphenylalanine; and combinations thereof; a synthase enzyme with specificity towards I-3,4-dihydroxyphenylalanine; a mutated synthase enzyme with specificity towards I-3,4-dihydroxyphenylalanine; a 3,4-dihydroxyphenyl-acetaldehyde synthase; a mutated 3,4- dihydroxyphenyl-acetaldehyde synthase with specificity towards I-3,4-dihydroxyphenylalanine; a dioxygenase enzyme with specificity towards I-3,4-dihydroxyphenylalanine; and a mutated dioxygenase enzyme with specificity towards I-3,4-dihydroxyphenylalanine.
Owner:NAJIB HIFZA +8

Cysteine protease structural domain mediated protein C-terminal selective modification method

The invention relates to a cysteine protease structural domain mediated protein C-terminal selective modification method. The method comprises the following steps: adding a nucleophilic reagent, a catalyst and a cysteine protease allosteric activator into a target protein fused with a cysteine protease structural domain (CPD) as shown in a formula (I), and releasing a C-terminal modified target protein while inducing CPD splitting decomposition. The invention also provides a CPD-catalyzed proteolysis method and a C-terminal modification conversion method on the basis of the C-terminal modification. The method disclosed by the invention has high flexibility and has a huge application prospect in C-terminal modification of protein molecules. # imgabs0 #
Owner:SHANGHAI INSTITUTE OF MATERIA MEDICA CHINESE ACADEMY OF SCIENCES

Pectin methylesterase mutant designed based on diffusion model as well as preparation and application of pectin methylesterase mutant

The invention provides a high-activity pectin methylesterase mutant designed based on a diffusion model as well as preparation and application of the high-activity pectin methylesterase mutant. The amino acid sequence of the pectin methylesterase mutant PME-DS12 is shown as SEQ ID NO: 2. According to the invention, the structure of the pectin methylesterase is redesigned by utilizing an RFdiffusion generative diffusion model, and the mutant PME-DS12 of which the enzyme activity is remarkably improved is obtained by screening. Compared with wild pectin methylesterase, the enzymatic activity of the PME-DS12 is improved by about 6.3 times, and the PME-DS12 has higher industrial application value. The mutant has wide application prospects in the fields of food processing, spinning and the like. In particular, in the aspect of flavor substance generation, macromolecular substances in food are degraded by the enzyme, so that the generation of aroma lipid substances is provided, and the aroma quality of a product is improved; the method can also be used in the papermaking industry, including biological bleaching of paper pulp, reduces the use of chemical reagents, and reduces environmental pollution.
Owner:ZHENGZHOU TOBACCO RES INST OF CNTC

PDA / PtCuO CDs-Gel, preparation method thereof and application of PDA / PtCuO CDs-Gel in preparation of antibacterial therapeutic agent

The invention discloses PDA / PtCuO CDs-Gel nano-enzyme composite gel and a preparation method and application thereof in preparation of an antibacterial therapeutic agent.The nano-enzyme composite gel is of a gel-wrapped nano-enzyme structure, PtCuO serves as a core of the nano-enzyme, a polydopamine layer is arranged outside the core, the polydopamine layer is modified with carbon quantum dots, and the carbon quantum dots are modified with PtCuO. The PtCuO is CuO nano particles of which the surfaces are modified with Pt nano particles. According to the nano-enzyme composite gel, H2O2 does not need to be added as an enzyme reaction substrate, the catalytic efficiency is high, the antibacterial performance is high, the cell penetrability and the photothermal conversion efficiency are high, and multi-mode antibacterial treatment can be achieved.
Owner:NANJING TECH UNIV

Systems and methods for sensing levodopa

PCT designated stage expiredWO2025117253A9Microbiological testing/measurementCatheterDihydroxy-L-phenylalanineOxygenase
A Levodopa-selective sensor is provided. A continuous levodopa monitor is also provided. The levodopa sensor includes a sensor area having a working electrode with a levodopa-selective chemistry configured for at least partial implantation in a host. The sensor also includes at least one membrane adjacent the levodopa-selective chemistry. The at least one membrane includes an enzyme domain that at least one enzyme selected from a tyrosinase; a mutated tyrosinase with specificity towards I-3,4-dihydroxyphenylalanine; a dihydroxyphenylalanine 4,5-dioxygenase; a mutated dihydroxyphenylalanine 4,5-dioxygenase with specificity towards I-3,4-dihydroxyphenylalanine; and combinations thereof; a synthase enzyme with specificity towards I-3,4-dihydroxyphenylalanine; a mutated synthase enzyme with specificity towards I-3,4-dihydroxyphenylalanine; a 3,4-dihydroxyphenyl-acetaldehyde synthase; a mutated 3,4- dihydroxyphenyl-acetaldehyde synthase with specificity towards I-3,4-dihydroxyphenylalanine; a dioxygenase enzyme with specificity towards I-3,4-dihydroxyphenylalanine; and a mutated dioxygenase enzyme with specificity towards I-3,4-dihydroxyphenylalanine.
Owner:NAJIB HIFZA +8

Transposase and use thereof

The present disclosure relates generally to transposase domains, in particular transposase domains comprising an amino terminal deletion, as well as transposase domains that form obligate heterodimers and transposase domains comprising a DNA targeting domain.
Owner:POSEIDA THERAPEUTICS INC

Untranslated regions and poly(A) tail sequences for use in methods and compositions for genome modulation

(1) An artificial nucleic acid molecule comprising (a) at least one of a 3'-untranslated region (3'UTR) element and / or (b) a 5'-untranslated region (5'UTR) element, and (2) a poly(A) tail is described. The artificial nucleic acid molecule may further comprise a polypeptide comprising a reverse transcriptase (RT) domain and optionally an endonuclease domain for genome modification. A system comprising the artificial nucleic acid molecule and a method of using the system are also described.
Owner:TESSERA THERAPEUTICS INC

Extraction process of papain

The invention relates to the technical field of enzyme extraction, in particular to an extraction process of papain. The invention discloses an extraction process of papain. The extraction process comprises the following steps: (1) taking supernate from immature papaya; (2) stirring and mixing the supernatant and the aqueous two-phase liquid, and standing for phase splitting to obtain a lower phase; (3) collecting a lower phase, and removing impurities through ultrafiltration to obtain a concentrated solution; and freeze-drying the concentrated solution to obtain enzyme powder. According to the extraction process disclosed by the invention, an organic solvent is replaced by a two-aqueous-phase liquid, mild phase splitting is realized through the synergistic effect of a surfactant and salt, and the damage to an enzyme structure is reduced; and further purifying and maintaining the enzyme activity by combining ultrafiltration and freeze drying.
Owner:SHANDONG BENON BIOLOGICAL TECHNOLOGY CO LTD

Bio-enzyme catalytic function key feature screening method and device, electronic equipment and storage medium

The invention provides a biological enzyme catalytic function key feature screening method and device, electronic equipment and a storage medium. Obtaining biological enzyme characteristics and enzyme catalytic activity; performing feature selection by adopting a recursive feature elimination method based on a random forest algorithm, and screening out key features of the biological enzyme; training a random forest model by using the screened biological enzyme key features, and obtaining a random forest model based on an optimal hyper-parameter value; and inputting the key features of the biological enzyme of the sample to be detected into the random forest model based on the optimal hyper-parameter value, obtaining a predicted value of the catalytic activity of the biological enzyme of the sample, and quantitatively calculating the contribution value of each key feature to the catalytic activity based on the predicted value. According to the method, key features influencing the catalytic function of the biological enzyme can be screened out from hundreds of millions of biological enzyme structures, charges and other features, the quantitative relation between the key features of the biological enzyme and the catalytic function is disclosed by utilizing a Shapliadditive interpretation algorithm, and guidance is provided for designing industrial biological enzymes with high catalytic activity and high selectivity.
Owner:SHANDONG UNIV

Methods of targeted genetic alteration in plant cells

The current invention relates to methods of targeted genetic alteration in cells, preferably plant cells, as well as to plant cells and plants thus obtained using at least a fusion protein comprising a site-specific nuclease domain and a deaminase domain, or a construct encoding the same. The method also provides for a composition and a kit comprising a combination of a first fusion protein comprising a cytosine deaminase domain and a second fusion protein comprising an adenine deaminase domain, preferably for use in the method of the invention. The method provides for targeted alteration of a DNA duplex in plant cells with increased efficacy.
Owner:KEYGENE NV

Nucleic acid ligation method

The present disclosure relates to biocatalytic ligation methods for producing oligonucleotides; and to fusion polypeptides for use in said methods. In particular, the disclosure relates to biocatalytic ligation methods incorporating ATP regeneration, and to fusion polypeptides comprising a polyphosphate kinase domain and an ATP-dependent nucleic acid ligase domain.
Owner:NOVARTIS AG

Streptoproteinase compound preparation with mucus removing and defoaming functions and preparation process of streptoproteinase compound preparation

The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to a streptavidin compound preparation with mucus removing and defoaming functions and a preparation process thereof. The preparation consists of streptavidin, sodium bicarbonate, dimeticone, silicon dioxide, polysorbate 80 and a filler / adhesive. The preparation method comprises the following steps: stirring dimeticone and silicon dioxide at 145-155 DEG C to react for 7-8 hours to form a compound through a step-by-step granulation process, performing wet granulation, mixing active ingredients at low temperature, and finally performing dry granulation and sub-packaging. The method is characterized in that 1) streptavidin and dimeticone synergistically decompose mucin and break bubbles, and double-view interference is synchronously eliminated; the pH value in the stomach is maintained to be 7-10 through sodium bicarbonate, the enzyme activity is guaranteed, step-by-step granulation avoids high-temperature damage to the enzyme structure, and 5-minute rapid disintegration is achieved through the 80-mesh sieve granule control technology. The preoperative process is simplified, the drug synergism is improved, and the preparation is suitable for gastroscopy and other scenes.
Owner:JIANGSU SHENQU PHARM CO LTD

A glutamate decarboxylase multi-site combined mutant and application thereof

The application discloses a glutamate decarboxylase multi-site combined mutant and application thereof. The application finds key sites by analyzing the enzyme structure and amino acid sequence of glutamate decarboxylase from Bifidobacterium breve and human GAD65, finally the key amino acid residue sites in the catalytic region and the vicinity of the active center are reformed (C168M, V167F, Y165S, F304Y, Y308F), so that the catalytic activity and specificity of the glutamate decarboxylase are regulated, the reaction type is changed from decarboxylation to incomplete oxidation, and the catalysis of glutamic acid forms the oxidation byproduct succinamic acid. In the process of GAD producing succinamic acid, the side reaction is enhanced, and the main reaction is weakened, so that the produced GABA is further oxidized into succinamic acid. The biological catalysis method can effectively improve the screening probability of the mutant amino acid sites, improve the experimental efficiency and feasibility, and screen the mutant enzyme with enzyme activity obviously superior to the parent enzyme.
Owner:SHANDONG YANGCHENG BIOLOGY TECH CO LTD

Preparation method of in-situ encapsulated enzyme material based on metal polyphenol network

PendingCN120536423AImmobilised enzymesOxidoreductasesEnzyme encapsulationEnzyme structure
The invention discloses a preparation method of an in-situ encapsulated enzyme material based on a metal polyphenol network, and belongs to the field of immobilized enzyme preparation. The preparation method comprises the following steps: firstly, fully mixing glucose oxidase (GOx) and tannic acid (TA), and combining the glucose oxidase (GOx) and the tannic acid (TA) through hydrogen bonds and hydrophobic interaction to form a TA-GOx compound; then adding a FeCl3. 6H2O solution, oscillating by using a vortex oscillator, and forming a metal polyphenol network through a rapid coordination reaction to package the enzyme inside in a lossless manner, so as to realize the construction of an enzyme in-situ packaging system. The preparation method of the metal polyphenol network in-situ encapsulated enzyme material (20s vortex, room temperature and aqueous solution) is simple, overcomes the limitations that the enzyme is easy to fall off, the enzyme structure is irreversibly damaged and the accessibility of enzyme active sites is poor, and breaks through the size limitation of the enzyme. And the polyphenol and the metal salt are low in industrial price, so that the simple and economical enzyme encapsulation technology has a wide application range and industrial application.
Owner:BEIJING UNIV OF CHEM TECH

Nucleic Acid Ligation Method

The present disclosure relates to biocatalytic ligation methods for generating oligonucleotides and fusion polypeptides for use in the methods. In particular, the disclosure relates to biocatalytic ligation methods that incorporate ATP regeneration and fusion polypeptides that include a polyphosphate kinase domain and an ATP-dependent nucleic acid ligase domain.
Owner:NOVARTIS AG

Nanometer antibody for hot start Taq DNA polymerase and construction method thereof

The invention belongs to the technical field of antibodies, and discloses a nano antibody for hot start of Taq DNA polymerase and a construction method of the nano antibody. The nano-antibody is a monovalent nano-antibody for sealing a 3 '-5' excision enzyme structural domain of Taq DNA polymerase, a monovalent nano-antibody for sealing a 5 '-3' polymerization active structural domain of Taq DNA polymerase or a bivalent nano-antibody obtained by connecting the monovalent nano-antibody and the monovalent nano-antibody through flexible peptide; the amino acid sequence of the monovalent nano antibody for sealing the 3 '-5' excision enzyme structural domain of the Taq DNA polymerase is shown as SEQ ID NO: 1, the amino acid sequence of the monovalent nano antibody for sealing the 5 '-3' polymerization active structural domain of the Taq DNA polymerase is shown as SEQ ID NO: 2, and the amino acid sequence of the flexible peptide is shown as SEQ ID NO: 3.
Owner:NANCHANG HIGH-TECH IND COLLABORATIVE INNOVATION INST CHINESE ACAD OF SCI +2

Prolyl hydroxylase domain-containing protein (PHD) inhibitor crystals and uses thereof

Described herein are crystalline forms of small molecule inhibitor compounds (1) of Prolyl Hydroxylase Domain-containing Protein (PHD) and pharmaceutical compositions thereof, and methods of their use in the treatment of diseases or conditions that would benefit from treatment with inhibitors of Prolyl Hydroxylase Domain-containing Protein (PHD). (1)
Owner:INSILICO MEDICINE IP LTD

Glucose dehydrogenase mutant G321R and application thereof

The invention relates to the technical field of bioengineering, and discloses a glucose dehydrogenase mutant G321R and application thereof. The method comprises the following steps: firstly, carrying out molecular docking on glucose dehydrogenase and a glucose substrate to obtain a series of amino acid sites possibly influencing the enzyme structure and the combination of the enzyme and the substrate, then carrying out virtual saturated mutation on amino acids of the sites, and screening out mutation possibly enhancing the enzyme stability and activity through molecular dynamics simulation. A plurality of amino acid sites and mutation schemes capable of improving the stability and activity of the glucose dehydrogenase are obtained through screening after large-scale expression of the glucose dehydrogenase, the stability and activity of mutants obtained through single-point mutation and multi-point combined mutation of the sites are improved to different degrees, and the mutants can be used for preparing the glucose dehydrogenase mutant. The compound has high activity, can improve detection sensitivity and accuracy when used for detecting blood glucose, has high stability, is suitable for preparing kits and the like, and has wide application prospects.
Owner:HANGZHOU BOYUE BIOTECHNOLOGY CO LTD

Improved system and method for producing recombinant DNA-packaged AAV particles

Provided herein are Rep proteins comprising mutated helicase domains, and methods using the Rep proteins for producing recombinant DNA-packaged AAV particles.
Owner:HUIDAGENE THERAPEUTICS (SINGAPORE) PTE LTD +1

A biological enzyme temperature control reaction equipment

The present invention belongs to the field of biological enzyme production equipment, and specifically is a biological enzyme temperature control reaction equipment, comprising a base, a machine base fixed on the top of the base, a rotating cross frame arranged on the top of the machine base, and a temperature control reaction equipment body arranged at the front and rear of the top of the rotating cross frame. The present invention drives a rotating column by a motor to make the rotating cross frame reciprocate with the rotating column as the center of a circle, and the rotating rotating cross frame drives the temperature control reaction equipment body at the two ends of the top to reciprocate. When the temperature control reaction equipment body reciprocates, the raw material tends to maintain the original motion state due to inertia. At the same time, the centrifugal force causes the raw material to move to the edge of the temperature control reaction equipment body. In the process of reciprocating rotation, the inertia and centrifugal force are constantly changing, resulting in the raw material flowing back and forth and exchanging between different positions, thereby achieving mixing. Compared with stirring, the reciprocating rotation for mixing the raw materials can reduce the shear force and reduce the risk of direct damage to the enzyme structure.
Owner:JIANGSU YINONG BIOLOGY CO LTD

Gene mining method combining functional sequence and structure simulation, NADH-preferring glufosinate dehydrogenase mutant and its application

The invention discloses a gene mining method combining functional sequence and structure simulation, a NADH-preferring glufosinate ammonium dehydrogenase mutant and application. The gene mining method comprises: (1) analyzing the characteristic sequence that NADH-type glutamate dehydrogenase should have; (2) searching a gene library according to the characteristic sequence; (3) performing cluster analysis and protein structure simulation on the searched genes; (4) selecting genes with high gene polymerization degree and protein structure similar to the known glufosinate ammonium dehydrogenase structure as candidate genes. A wild-type glufosinate ammonium dehydrogenase derived from Lysinibacillus composti with an amino acid sequence as shown in SEQ ID No. 2 is obtained through gene mining, and a NADH-preferring glufosinate ammonium dehydrogenase mutant is obtained through mutation screening, wherein the mutation site is selected from one of the following: (1) A144G-V375F-M91A; (2) A144G-V345A-M91A; (3) A144G, and the mutant enzyme can use the cheap coenzyme NAD for catalytic reaction.
Owner:ZHEJIANG UNIV OF TECH

Application of untranslated region and poly (A) tail sequence in genome regulation method and composition

Described are compositions comprising (1) at least one of: (a) a 3 '-untranslated region (3' UTR) element and / or (b) a 5 '-untranslated region (5' UTR) element; and (2) an artificial nucleic acid molecule with a poly (A) tail. The artificial nucleic acid molecule may further comprise a polypeptide comprising a reverse transcriptase (RT) domain and optionally an endonuclease domain for genome modification. Systems comprising the artificial nucleic acid molecules and methods of using the systems are also described.
Owner:TESSERA THERAPEUTICS INC

Mutants of paenibacillus and methods for their use

The present invention provides a composition comprising a biologically pure culture of a Paenibacillus sp. strain comprising a mutant DegU lacking a functional receiver domain or a functional DNA binding domain and / or a mutant DegS lacking a functional single binding domain or a functional ATPase domain with decreased viscosity in a liquid culture. Also provided is a method of identifying a Paenibacillus sp. mutant derivative strain with decreased viscosity in a liquid culture compared to a Paenibacillus sp. parental strain with a visual screen for mutant isolates with a non-mucoid morphology.
Owner:BAYER CROPSCIENCE LLC

Highly efficient base editing system, preparation method therefor and use thereof

Provided are a highly efficient base editing system, a preparation method therefor and the use thereof. Specifically, provided is a fusion protein, comprising a nuclease domain and an editing enzyme domain, wherein the editing enzyme domain is inserted into an insertion site in the nuclease domain. The nuclease domain in the fusion protein has the function of a nuclease, the editing enzyme domain in the fusion protein has the function of an editing enzyme, and the nuclease domain is derived from a Cas protein or a Cas protein mutant. On the basis of an activation-induced cytosine deaminase (AID), a new AID mutant having a shorter sequence and higher base editing efficiency is obtained by means of screening, and then the highly active AID mutant is randomly inserted into nSaCas9 (D10A) KKH, such that a new cytosine base editor EB-TAM having high base editing efficiency and an expanded and narrowed editing scope is successfully obtained by means of screening.
Owner:SUZHOU GENASSIST THERAPEUTICS CO LTD